Allen Hubert L's Form 4 filing
Abbott Laboratories (ABT) · filed Oct 23, 2024
- Accession no.
- 0001415889-24-025575
- Filed
- Oct 23, 2024
- Trade date
- Oct 21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $18.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allen Hubert LCIK 0001565916 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Common shares without par value | MOption exerciseAcquired | +157,421 | $47.00 | +$7,398,787 | 342,227 | Direct | |
| Oct 21, 2024 | Common shares without par value | SSaleDisposed | −1,249 | $118.81 | −$148,393.69 | 340,978 | Direct | |
| Oct 21, 2024 | Common shares without par value | SSaleDisposed | −5,901 | $118.15 | −$697,203.15 | 335,077 | Direct | |
| Oct 21, 2024 | Common shares without par value | SSaleDisposed | −150,271 | $116.98 | −$17,578,701.58 | 184,806 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Common shares | MOption exerciseDisposed | −157,421 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.